SG11202100894XA - Methods for purifying isavuconazonium sulfate - Google Patents

Methods for purifying isavuconazonium sulfate

Info

Publication number
SG11202100894XA
SG11202100894XA SG11202100894XA SG11202100894XA SG11202100894XA SG 11202100894X A SG11202100894X A SG 11202100894XA SG 11202100894X A SG11202100894X A SG 11202100894XA SG 11202100894X A SG11202100894X A SG 11202100894XA SG 11202100894X A SG11202100894X A SG 11202100894XA
Authority
SG
Singapore
Prior art keywords
purifying
methods
isavuconazonium sulfate
isavuconazonium
sulfate
Prior art date
Application number
SG11202100894XA
Inventor
Weipeng Zeng
Marco Mazzotti
Lars Vicum
Jeroen Cornel
Markus Heubes
Michael Schleimer
Original Assignee
Basilea Pharm Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharm Int Ag filed Critical Basilea Pharm Int Ag
Publication of SG11202100894XA publication Critical patent/SG11202100894XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00Purification; Separation; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
SG11202100894XA 2018-08-01 2019-07-29 Methods for purifying isavuconazonium sulfate SG11202100894XA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2018097881 2018-08-01
CN2019090347 2019-06-06
PCT/EP2019/070385 WO2020025553A1 (en) 2018-08-01 2019-07-29 Methods for purifying isavuconazonium sulfate

Publications (1)

Publication Number Publication Date
SG11202100894XA true SG11202100894XA (en) 2021-02-25

Family

ID=67660058

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202100894XA SG11202100894XA (en) 2018-08-01 2019-07-29 Methods for purifying isavuconazonium sulfate

Country Status (13)

Country Link
US (1) US20210323959A1 (en)
EP (1) EP3830084A1 (en)
JP (1) JP7433288B2 (en)
KR (1) KR20210040034A (en)
CN (1) CN112469717A (en)
AU (1) AU2019313525A1 (en)
BR (1) BR112021000486A2 (en)
CA (1) CA3103888A1 (en)
IL (1) IL279667A (en)
MX (1) MX2021001116A (en)
SG (1) SG11202100894XA (en)
TW (1) TW202019920A (en)
WO (1) WO2020025553A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023148544A1 (en) * 2022-02-04 2023-08-10 Glenmark Life Sciences Limited Crystalline form of isavuconazonium sulfate and a process for its preparation
WO2023238014A1 (en) * 2022-06-09 2023-12-14 Optimus Drugs Private Limited Crystalline form p of isavuconazonium sulfate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1280795E (en) 1999-11-02 2005-06-30 Basilea Pharmaceutica Ag N-SUBSTITUTED CARBAMOYL-AZALYL DERIVATIVES
MX2015007156A (en) 2012-12-07 2015-10-14 Hoffmann La Roche Pyridine-2-amides useful as cb2 agonists.
WO2016016766A2 (en) 2014-07-26 2016-02-04 Wockhardt Limited A process for the preparation of isavuconazonium or its salt thereof
CN106467534B (en) * 2015-08-17 2019-10-11 江苏奥赛康药业有限公司 A kind of sulfuric acid Chinese mugwort Saperconazole compound and its pharmaceutical composition
CN106565699B (en) 2015-10-10 2019-07-26 江苏正大丰海制药有限公司 A kind of Chinese mugwort Saperconazole vitriol and preparation method thereof
CN106883226A (en) 2017-03-30 2017-06-23 成都绿林科技有限公司 The preparation method of Ai Shakang azoles sulfuric esters
CN106916152B (en) 2017-04-27 2019-09-17 扬子江药业集团有限公司 The method of redox reaction preparation Chinese mugwort Saperconazole monosulfate

Also Published As

Publication number Publication date
JP2021533116A (en) 2021-12-02
BR112021000486A2 (en) 2021-04-06
JP7433288B2 (en) 2024-02-19
CA3103888A1 (en) 2020-02-06
TW202019920A (en) 2020-06-01
EP3830084A1 (en) 2021-06-09
WO2020025553A1 (en) 2020-02-06
AU2019313525A1 (en) 2021-01-07
US20210323959A1 (en) 2021-10-21
IL279667A (en) 2021-03-01
CN112469717A (en) 2021-03-09
KR20210040034A (en) 2021-04-12
MX2021001116A (en) 2021-03-31

Similar Documents

Publication Publication Date Title
IL271990A (en) Methods for the purification of l-glufosinate
IL281804A (en) Protein purification methods
IL265016B (en) Methods for purifying antibodies
IL280140A (en) Antigen purification method
IL272807A (en) Method for purifying proteins
GB201803724D0 (en) Methods
IL279667A (en) Methods for purifying isavuconazonium sulfate
GB201907882D0 (en) Methods
GB201802486D0 (en) Methods
GB201913716D0 (en) Methods
SG11202007342QA (en) Methods
GB201805466D0 (en) Methods
IL289959A (en) Methods for purifying antibodies
IL277056A (en) Methods for purifying antibodies
GB201600158D0 (en) Purification method
GB2584562B (en) Purification method
GB201906705D0 (en) Methods
GB201903909D0 (en) Methods
GB201901817D0 (en) Methods
HK1257713A1 (en) Method for protein purification
GB201814451D0 (en) Methods
IL276816A (en) Antibody purification
IL287609A (en) Purification method
ZA201905435B (en) Method for purifying water
GB201911910D0 (en) Methods